62 related articles for article (PubMed ID: 8701988)
1. Identification and partial characterization of a novel membrane-associated protein (MAP17) up-regulated in human carcinomas and modulating cell replication and tumor growth.
Kocher O; Cheresh P; Lee SW
Am J Pathol; 1996 Aug; 149(2):493-500. PubMed ID: 8701988
[TBL] [Abstract][Full Text] [Related]
2. Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains.
Kocher O; Comella N; Tognazzi K; Brown LF
Lab Invest; 1998 Jan; 78(1):117-25. PubMed ID: 9461128
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel gene, selectively up-regulated in human carcinomas, using the differential display technique.
Kocher O; Cheresh P; Brown LF; Lee SW
Clin Cancer Res; 1995 Oct; 1(10):1209-15. PubMed ID: 9815914
[TBL] [Abstract][Full Text] [Related]
4. PDZK1-Interacting Protein 1(PDZKIP1) Inhibits Goat Subcutaneous Preadipocyte Differentiation through Promoting Autophagy.
Chen D; Li Y; Hu T; Gong C; Lu G; Ma X; Wang Y; Wang Y; Lin Y
Animals (Basel); 2023 Mar; 13(6):. PubMed ID: 36978587
[TBL] [Abstract][Full Text] [Related]
5. A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma.
Zhou RW; Xu J; Martin TC; Zachem AL; He J; Ozturk S; Demircioglu D; Bansal A; Trotta AP; Giotti B; Gryder B; Shen Y; Wu X; Carcamo S; Bosch K; Hopkins B; Tsankov A; Steinhagen R; Jones DR; Asara J; Chipuk JE; Brody R; Itzkowitz S; Chio IIC; Hasson D; Bernstein E; Parsons RE
Nat Commun; 2022 Oct; 13(1):6041. PubMed ID: 36253360
[TBL] [Abstract][Full Text] [Related]
6. The expression and survival significance of sodium glucose transporters in pancreatic cancer.
Du J; Gu J; Deng J; Kong L; Guo Y; Jin C; Bao Y; Fu D; Li J
BMC Cancer; 2022 Jan; 22(1):116. PubMed ID: 35090421
[TBL] [Abstract][Full Text] [Related]
7. Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells.
García-Heredia JM; Otero-Albiol D; Pérez M; Pérez-Castejón E; Muñoz-Galván S; Carnero A
Oncogenesis; 2020 Oct; 9(10):96. PubMed ID: 33106480
[TBL] [Abstract][Full Text] [Related]
8. PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-β (TGF-β) signaling.
Ikeno S; Nakano N; Sano K; Minowa T; Sato W; Akatsu R; Sakata N; Hanagata N; Fujii M; Itoh F; Itoh S
J Biol Chem; 2019 Mar; 294(13):4966-4980. PubMed ID: 30718277
[TBL] [Abstract][Full Text] [Related]
9. NaPi-IIa interacting partners and their (un)known functional roles.
Hernando N
Pflugers Arch; 2019 Jan; 471(1):67-82. PubMed ID: 30022249
[TBL] [Abstract][Full Text] [Related]
10. Dr. Jekyll and Mr. Hyde: MAP17's up-regulation, a crosspoint in cancer and inflammatory diseases.
García-Heredia JM; Carnero A
Mol Cancer; 2018 Apr; 17(1):80. PubMed ID: 29650022
[TBL] [Abstract][Full Text] [Related]
11. EGFR-TKI resistance and MAP17 are associated with cancer stem cell like properties.
Shao Y; Lv H; Zhong DS; Zhou QH
Oncol Lett; 2018 May; 15(5):6655-6665. PubMed ID: 29616128
[TBL] [Abstract][Full Text] [Related]
12. The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.
García-Heredia JM; Carnero A
Oncotarget; 2017 Nov; 8(58):98580-98597. PubMed ID: 29228712
[TBL] [Abstract][Full Text] [Related]
13. Saving the sweetness: renal glucose handling in health and disease.
Shepard BD; Pluznick JL
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F55-F61. PubMed ID: 28356283
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).
Perez M; Peinado-Serrano J; Garcia-Heredia JM; Felipe-Abrio I; Tous C; Ferrer I; Martin-Broto J; Saez C; Carnero A
Oncotarget; 2016 Oct; 7(41):67033-67046. PubMed ID: 27563810
[TBL] [Abstract][Full Text] [Related]
15. MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2.
Coady MJ; El Tarazi A; Santer R; Bissonnette P; Sasseville LJ; Calado J; Lussier Y; Dumayne C; Bichet DG; Lapointe JY
J Am Soc Nephrol; 2017 Jan; 28(1):85-93. PubMed ID: 27288013
[TBL] [Abstract][Full Text] [Related]
16. MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival.
Perez M; Praena-Fernandez JM; Felipe-Abrio B; Lopez-Garcia MA; Lucena-Cacace A; Garcia A; Lleonart M; Roncador G; Marin JJ; Carnero A
PLoS One; 2013; 8(2):e56169. PubMed ID: 23418532
[TBL] [Abstract][Full Text] [Related]
17. MAP17, a ROS-dependent oncogene.
Carnero A
Front Oncol; 2012; 2():112. PubMed ID: 22973555
[TBL] [Abstract][Full Text] [Related]
18. Monitoring protein-protein interactions between the mammalian integral membrane transporters and PDZ-interacting partners using a modified split-ubiquitin membrane yeast two-hybrid system.
Gisler SM; Kittanakom S; Fuster D; Wong V; Bertic M; Radanovic T; Hall RA; Murer H; Biber J; Markovich D; Moe OW; Stagljar I
Mol Cell Proteomics; 2008 Jul; 7(7):1362-77. PubMed ID: 18407958
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome sequencing of malignant pleural mesothelioma tumors.
Sugarbaker DJ; Richards WG; Gordon GJ; Dong L; De Rienzo A; Maulik G; Glickman JN; Chirieac LR; Hartman ML; Taillon BE; Du L; Bouffard P; Kingsmore SF; Miller NA; Farmer AD; Jensen RV; Gullans SR; Bueno R
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3521-6. PubMed ID: 18303113
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of novel potential regulators in hematopoietic stem cells.
Forsberg EC; Prohaska SS; Katzman S; Heffner GC; Stuart JM; Weissman IL
PLoS Genet; 2005 Sep; 1(3):e28. PubMed ID: 16151515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
